Curcumin Collaborative Project

2010

This collaborative project will identify and characterize novel curcumin-like derivatives for the treatment and prevention of Alzheimer’s disease. The purpose of the study is to develop means of overcoming obstacles to rapid breakdown and creating methodologies for precisely delivering curcumin derivatives to appropriate locations within the brain.


Funding to Date

$400,000

Focus

Drug Discovery, Drug Screening Projects

Researchers

Rudolph Tanzi, Ph.D.


William Klunk, M.D., Ph.D.